カテゴリー： QYResearch, 世界, 医療/バイオ

世界の疼痛治療薬市場インサイト及び予測（オピオイド、NSAID、その他）

◆英語タイトル：Global Pain Treatment Drug Market Insights, Forecast to 2028
	◆商品コード：QY22JLX10455 ◆発行会社（リサーチ会社）：QYResearch ◆発行日：2022年7月（※2025年版があります。お問い合わせください。） ◆ページ数：114 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD4,900 ⇒換算￥744,800	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD7,350 ⇒換算￥1,117,200	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD9,800 ⇒換算￥1,489,600	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、疼痛治療薬のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に疼痛治療薬の世界市場のxxx％を占める「オピオイド」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
疼痛治療薬の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの疼痛治療薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

疼痛治療薬のグローバル主要企業には、Pfizer、GSK、Grunenthal、Bayer、Sanofi、Eli Lilly、AstraZeneca、Endo、Merck、Depomed、Yunnan Baiyao、Teva、J&J、Teikoku、Allergan、Purdueなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

疼痛治療薬市場は、種類と用途によって区分されます。世界の疼痛治療薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
オピオイド、NSAID、その他

【用途別セグメント】
病院、ドラッグストア、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 疼痛治療薬製品概要
- 種類別市場（オピオイド、NSAID、その他）
- 用途別市場（病院、ドラッグストア、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界の疼痛治療薬販売量予測2017-2028
- 世界の疼痛治療薬売上予測2017-2028
- 疼痛治療薬の地域別販売量
- 疼痛治療薬の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別疼痛治療薬販売量
- 主要メーカー別疼痛治療薬売上
- 主要メーカー別疼痛治療薬価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（オピオイド、NSAID、その他）
- 疼痛治療薬の種類別販売量
- 疼痛治療薬の種類別売上
- 疼痛治療薬の種類別価格
・用途別市場規模（病院、ドラッグストア、その他）
- 疼痛治療薬の用途別販売量
- 疼痛治療薬の用途別売上
- 疼痛治療薬の用途別価格
・北米市場
- 北米の疼痛治療薬市場規模（種類別、用途別）
- 主要国別の疼痛治療薬市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの疼痛治療薬市場規模（種類別、用途別）
- 主要国別の疼痛治療薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の疼痛治療薬市場規模（種類別、用途別）
- 主要国別の疼痛治療薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の疼痛治療薬市場規模（種類別、用途別）
- 主要国別の疼痛治療薬市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの疼痛治療薬市場規模（種類別、用途別）
- 主要国別の疼痛治療薬市場規模（トルコ、サウジアラビア）
・企業情報
Pfizer、GSK、Grunenthal、Bayer、Sanofi、Eli Lilly、AstraZeneca、Endo、Merck、Depomed、Yunnan Baiyao、Teva、J&J、Teikoku、Allergan、Purdue
・産業チェーン及び販売チャネル分析
- 疼痛治療薬の産業チェーン分析
- 疼痛治療薬の原材料
- 疼痛治療薬の生産プロセス
- 疼痛治療薬の販売及びマーケティング
- 疼痛治療薬の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 疼痛治療薬の産業動向
- 疼痛治療薬のマーケットドライバー
- 疼痛治療薬の課題
- 疼痛治療薬の阻害要因
・主な調査結果

Pain is complex, so there are many treatment options — medications, therapies, and mind-body techniques.
Market Analysis and Insights: Global Pain Treatment Drug Market
The global Pain Treatment Drug market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Opioids accounting for % of the Pain Treatment Drug global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Pain Treatment Drug market size is valued at US$ million in 2021, while the North America and Europe Pain Treatment Drug are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Pain Treatment Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pain Treatment Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pain Treatment Drug market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pain Treatment Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pain Treatment Drug market.
Global Pain Treatment Drug Scope and Market Size
Pain Treatment Drug market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Pain Treatment Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Opioids
NSAIDs
Others
Segment by Application
Hospitals
Drugstores
Others
By Company
Pfizer
GSK
Grunenthal
Bayer
Sanofi
Eli Lilly
AstraZeneca
Endo
Merck
Depomed
Yunnan Baiyao
Teva
J&J
Teikoku
Allergan
Purdue
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

❖ レポートの目次 ❖

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pain Treatment Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Opioids
1.2.3 NSAIDs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Pain Treatment Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pain Treatment Drug Market Perspective (2017-2028)
2.2 Pain Treatment Drug Growth Trends by Region
2.2.1 Pain Treatment Drug Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Pain Treatment Drug Historic Market Size by Region (2017-2022)
2.2.3 Pain Treatment Drug Forecasted Market Size by Region (2023-2028)
2.3 Pain Treatment Drug Market Dynamics
2.3.1 Pain Treatment Drug Industry Trends
2.3.2 Pain Treatment Drug Market Drivers
2.3.3 Pain Treatment Drug Market Challenges
2.3.4 Pain Treatment Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pain Treatment Drug Players by Revenue
3.1.1 Global Top Pain Treatment Drug Players by Revenue (2017-2022)
3.1.2 Global Pain Treatment Drug Revenue Market Share by Players (2017-2022)
3.2 Global Pain Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pain Treatment Drug Revenue
3.4 Global Pain Treatment Drug Market Concentration Ratio
3.4.1 Global Pain Treatment Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pain Treatment Drug Revenue in 2021
3.5 Pain Treatment Drug Key Players Head office and Area Served
3.6 Key Players Pain Treatment Drug Product Solution and Service
3.7 Date of Enter into Pain Treatment Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pain Treatment Drug Breakdown Data by Type
4.1 Global Pain Treatment Drug Historic Market Size by Type (2017-2022)
4.2 Global Pain Treatment Drug Forecasted Market Size by Type (2023-2028)
5 Pain Treatment Drug Breakdown Data by Application
5.1 Global Pain Treatment Drug Historic Market Size by Application (2017-2022)
5.2 Global Pain Treatment Drug Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Pain Treatment Drug Market Size (2017-2028)
6.2 North America Pain Treatment Drug Market Size by Type
6.2.1 North America Pain Treatment Drug Market Size by Type (2017-2022)
6.2.2 North America Pain Treatment Drug Market Size by Type (2023-2028)
6.2.3 North America Pain Treatment Drug Market Share by Type (2017-2028)
6.3 North America Pain Treatment Drug Market Size by Application
6.3.1 North America Pain Treatment Drug Market Size by Application (2017-2022)
6.3.2 North America Pain Treatment Drug Market Size by Application (2023-2028)
6.3.3 North America Pain Treatment Drug Market Share by Application (2017-2028)
6.4 North America Pain Treatment Drug Market Size by Country
6.4.1 North America Pain Treatment Drug Market Size by Country (2017-2022)
6.4.2 North America Pain Treatment Drug Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Pain Treatment Drug Market Size (2017-2028)
7.2 Europe Pain Treatment Drug Market Size by Type
7.2.1 Europe Pain Treatment Drug Market Size by Type (2017-2022)
7.2.2 Europe Pain Treatment Drug Market Size by Type (2023-2028)
7.2.3 Europe Pain Treatment Drug Market Share by Type (2017-2028)
7.3 Europe Pain Treatment Drug Market Size by Application
7.3.1 Europe Pain Treatment Drug Market Size by Application (2017-2022)
7.3.2 Europe Pain Treatment Drug Market Size by Application (2023-2028)
7.3.3 Europe Pain Treatment Drug Market Share by Application (2017-2028)
7.4 Europe Pain Treatment Drug Market Size by Country
7.4.1 Europe Pain Treatment Drug Market Size by Country (2017-2022)
7.4.2 Europe Pain Treatment Drug Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pain Treatment Drug Market Size (2017-2028)
8.2 Asia-Pacific Pain Treatment Drug Market Size by Type
8.2.1 Asia-Pacific Pain Treatment Drug Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Pain Treatment Drug Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Pain Treatment Drug Market Share by Type (2017-2028)
8.3 Asia-Pacific Pain Treatment Drug Market Size by Application
8.3.1 Asia-Pacific Pain Treatment Drug Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Pain Treatment Drug Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Pain Treatment Drug Market Share by Application (2017-2028)
8.4 Asia-Pacific Pain Treatment Drug Market Size by Region
8.4.1 Asia-Pacific Pain Treatment Drug Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Pain Treatment Drug Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pain Treatment Drug Market Size (2017-2028)
9.2 Latin America Pain Treatment Drug Market Size by Type
9.2.1 Latin America Pain Treatment Drug Market Size by Type (2017-2022)
9.2.2 Latin America Pain Treatment Drug Market Size by Type (2023-2028)
9.2.3 Latin America Pain Treatment Drug Market Share by Type (2017-2028)
9.3 Latin America Pain Treatment Drug Market Size by Application
9.3.1 Latin America Pain Treatment Drug Market Size by Application (2017-2022)
9.3.2 Latin America Pain Treatment Drug Market Size by Application (2023-2028)
9.3.3 Latin America Pain Treatment Drug Market Share by Application (2017-2028)
9.4 Latin America Pain Treatment Drug Market Size by Country
9.4.1 Latin America Pain Treatment Drug Market Size by Country (2017-2022)
9.4.2 Latin America Pain Treatment Drug Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pain Treatment Drug Market Size (2017-2028)
10.2 Middle East & Africa Pain Treatment Drug Market Size by Type
10.2.1 Middle East & Africa Pain Treatment Drug Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Pain Treatment Drug Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Pain Treatment Drug Market Share by Type (2017-2028)
10.3 Middle East & Africa Pain Treatment Drug Market Size by Application
10.3.1 Middle East & Africa Pain Treatment Drug Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Pain Treatment Drug Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Pain Treatment Drug Market Share by Application (2017-2028)
10.4 Middle East & Africa Pain Treatment Drug Market Size by Country
10.4.1 Middle East & Africa Pain Treatment Drug Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Pain Treatment Drug Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Pain Treatment Drug Introduction
11.1.4 Pfizer Revenue in Pain Treatment Drug Business (2017-2022)
11.1.5 Pfizer Recent Developments
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK Pain Treatment Drug Introduction
11.2.4 GSK Revenue in Pain Treatment Drug Business (2017-2022)
11.2.5 GSK Recent Developments
11.3 Grunenthal
11.3.1 Grunenthal Company Details
11.3.2 Grunenthal Business Overview
11.3.3 Grunenthal Pain Treatment Drug Introduction
11.3.4 Grunenthal Revenue in Pain Treatment Drug Business (2017-2022)
11.3.5 Grunenthal Recent Developments
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Pain Treatment Drug Introduction
11.4.4 Bayer Revenue in Pain Treatment Drug Business (2017-2022)
11.4.5 Bayer Recent Developments
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Pain Treatment Drug Introduction
11.5.4 Sanofi Revenue in Pain Treatment Drug Business (2017-2022)
11.5.5 Sanofi Recent Developments
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Pain Treatment Drug Introduction
11.6.4 Eli Lilly Revenue in Pain Treatment Drug Business (2017-2022)
11.6.5 Eli Lilly Recent Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Pain Treatment Drug Introduction
11.7.4 AstraZeneca Revenue in Pain Treatment Drug Business (2017-2022)
11.7.5 AstraZeneca Recent Developments
11.8 Endo
11.8.1 Endo Company Details
11.8.2 Endo Business Overview
11.8.3 Endo Pain Treatment Drug Introduction
11.8.4 Endo Revenue in Pain Treatment Drug Business (2017-2022)
11.8.5 Endo Recent Developments
11.9 Merck
11.9.1 Merck Company Details
11.9.2 Merck Business Overview
11.9.3 Merck Pain Treatment Drug Introduction
11.9.4 Merck Revenue in Pain Treatment Drug Business (2017-2022)
11.9.5 Merck Recent Developments
11.10 Depomed
11.10.1 Depomed Company Details
11.10.2 Depomed Business Overview
11.10.3 Depomed Pain Treatment Drug Introduction
11.10.4 Depomed Revenue in Pain Treatment Drug Business (2017-2022)
11.10.5 Depomed Recent Developments
11.11 Yunnan Baiyao
11.11.1 Yunnan Baiyao Company Details
11.11.2 Yunnan Baiyao Business Overview
11.11.3 Yunnan Baiyao Pain Treatment Drug Introduction
11.11.4 Yunnan Baiyao Revenue in Pain Treatment Drug Business (2017-2022)
11.11.5 Yunnan Baiyao Recent Developments
11.12 Teva
11.12.1 Teva Company Details
11.12.2 Teva Business Overview
11.12.3 Teva Pain Treatment Drug Introduction
11.12.4 Teva Revenue in Pain Treatment Drug Business (2017-2022)
11.12.5 Teva Recent Developments
11.13 J&J
11.13.1 J&J Company Details
11.13.2 J&J Business Overview
11.13.3 J&J Pain Treatment Drug Introduction
11.13.4 J&J Revenue in Pain Treatment Drug Business (2017-2022)
11.13.5 J&J Recent Developments
11.14 Teikoku
11.14.1 Teikoku Company Details
11.14.2 Teikoku Business Overview
11.14.3 Teikoku Pain Treatment Drug Introduction
11.14.4 Teikoku Revenue in Pain Treatment Drug Business (2017-2022)
11.14.5 Teikoku Recent Developments
11.15 Allergan
11.15.1 Allergan Company Details
11.15.2 Allergan Business Overview
11.15.3 Allergan Pain Treatment Drug Introduction
11.15.4 Allergan Revenue in Pain Treatment Drug Business (2017-2022)
11.15.5 Allergan Recent Developments
11.16 Purdue
11.16.1 Purdue Company Details
11.16.2 Purdue Business Overview
11.16.3 Purdue Pain Treatment Drug Introduction
11.16.4 Purdue Revenue in Pain Treatment Drug Business (2017-2022)
11.16.5 Purdue Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の疼痛治療薬市場インサイト及び予測（オピオイド、NSAID、その他）(Global Pain Treatment Drug Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界の疼痛治療薬市場インサイト及び予測（オピオイド、NSAID、その他）

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp